Baca berita tanpa iklan. Gabung Kompas.com+

Russia on a Mission to Produce Millions of Covid-19 Vaccines by 2021

August 4, 2020, 04.16 PM

MOSCOW, KOMPAS.com – On Monday, Russia shared its goal of mass-producing a Covid-19 vaccine next month and aims to have “several million” doses per month by 2021.

Russia is forging ahead with a range of Covid-19 vaccine prototypes and one trialed by the Gamaleya Institute in Moscow.

The latter has reached advanced stages of development and will soon pass state registration, according to officials.

"We are very much counting on starting mass production in September," Industry Minister Denis Manturov said in an interview published by state news agency TASS.

"We will be able to ensure production volumes of several hundred thousand a month, with an eventual increase to several million by the start of next year," he said, adding that one developer is preparing production technology at three locations in central Russia.

The head of the Russian Direct Investment Fund, which finances the trials, said he expects official registration of the vaccine to be complete "within 10 days."

"If this happens in the next 10 days, we will be ahead not just of the United States but other countries too, it will be the first registered coronavirus vaccine," RDIF chief Kirill Dmitriev said in televised remarks.

Another vaccine, developed by Siberia-based Vektor lab, is currently undergoing clinical trials and two more will begin human testing within the next two months, Health Minister Mikhail Murashko said on Saturday.

Gamaleya's vaccine is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding the needed immune response into cells.

Gamaleya's vaccine is based on the adenovirus, a similar technology to the coronavirus vaccine prototype developed by China's CanSino, currently in the advanced stage of clinical trials.

Who will buy it?

The state-run Gamaleya Institute came under fire after researchers and its director injected themselves with the prototype several months ago, with specialists criticizing the move as an unorthodox and rushed way of starting human trials.

Vitaly Zverev, laboratory chief at the Mechnikov Research Institute of Vaccines and Sera, said it was too early to register a vaccine.

"I believe a vaccine that is not properly checked must not be registered, no matter in what country," he said.

"It is impossible to ensure the vaccine's safety in the time that has passed since the beginning of this pandemic," he told AFP.

Page:


Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
April 14, 2023, 12.38 PM

Indonesia Detects New Covid Arcturus Variant

Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+

MOST POPULAR

Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+
Close Ads
Oke